Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19.
Mateo Porres-AguilarVictor F TapsonBelinda N Rivera-LebronParth M RaliDavid JiménezMateo Porres-MuñozSarah BarrazaOscar C MuñozDebabrata MukherjeePublished in: Journal of investigative medicine : the official publication of the American Federation for Clinical Research (2021)
Venous thromboembolism associated with COVID-19, particularly acute pulmonary embolism, may represent a challenging and complex clinical scenario. The benefits of having a multidisciplinary pulmonary embolism response team (PERT) can be important during such a pandemic. The aim of PERT in the care of such patients is to provide fast, appropriate, multidisciplinary, team-based approach, with the common goal to tailor the best therapeutic decision making, prioritizing always optimal patient care, especially given lack of evidence-based clinical practice guidelines in the setting of COVID-19, which potentially confers a significant prothrombotic state. Herein, we would like to briefly emphasize the importance and potential critical role of PERT in the care of patients in which these two devastating illnesses are present together.
Keyphrases
- pulmonary embolism
- coronavirus disease
- venous thromboembolism
- sars cov
- inferior vena cava
- end stage renal disease
- quality improvement
- palliative care
- newly diagnosed
- healthcare
- ejection fraction
- chronic kidney disease
- decision making
- prognostic factors
- peritoneal dialysis
- direct oral anticoagulants
- patient reported outcomes
- intensive care unit
- risk assessment
- atrial fibrillation
- drug induced
- human health